Alphacetylmethadol
Not to be confused with acetylmethadol[1]
Clinical data | |
---|---|
ATC code | None |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 1553-31-7 |
ChEMBL | CHEMBL2107793 |
Chemical and physical data | |
Formula | C23H31NO2 |
Molar mass | 353.5034 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Alphacetylmethadol (INN), or α-acetylmethadol (AAM), is a synthetic opioid analgesic.[2] Its levorotary enantiomer, levacetylmethadol, is an FDA-approved treatment for opioid addiction.[2] Alphacetylmethadol is very similar in structure to methadone, a widely prescribed treatment for opioid addiction. In the United States, it is a Schedule I controlled substance under the Controlled Substances Act (presumably because it was never marketed in the US, as is the case with other common opiate/opioid medications such as diacetylmorphine and alphaprodine), with an ACSCN of 9603 and a 2013 annual manufacturing quota of 2 grammes.[3]
See also
References
- ↑ Richard Lawrence Miller (30 December 2002). The Encyclopedia of Addictive Drugs. Greenwood Publishing Group. p. 222. ISBN 978-0-313-31807-8. Retrieved 15 May 2012.
- 1 2 Newman JL, Vann RE, May EL, Beardsley PM (October 2002). "Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats". Psychopharmacology. 164 (1): 108–14. doi:10.1007/s00213-002-1198-8. PMID 12373424.
- ↑ 21 U.S.C. § 812(b)(1)
Opioids | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Paracetamol-type |
| ||||||||||||||||||||||||||||||
NSAIDs |
| ||||||||||||||||||||||||||||||
Cannabinoids | |||||||||||||||||||||||||||||||
Ion channel modulators |
| ||||||||||||||||||||||||||||||
Myorelaxants | |||||||||||||||||||||||||||||||
Others | |||||||||||||||||||||||||||||||
|
MOR |
|
---|---|
DOR |
|
KOR |
|
NOP |
|
Unsorted |
|
Others |
|
See also: Peptide receptor modulators |
This article is issued from Wikipedia - version of the 11/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.